A RESOLUTION designating May as Asthma and Allergy Awareness Month.
Summary
SR287 is a Senate resolution that designates May 2026 as Asthma and Allergy Awareness Month in Kentucky. The resolution recites statistics about the prevalence and health impacts of asthma and food allergies nationally and in Kentucky, including emergency room visits, hospitalizations, school absences, deaths, and the disproportionate burden on Black, Hispanic, and Indigenous communities. It also notes that people with asthma and food allergies need access to affordable health insurance, medications, and medical devices.
The operative provisions are limited to a ceremonial proclamation and a public awareness directive. The Kentucky Senate formally proclaims May 2026 as Asthma and Allergy Awareness Month, encourages citizens to support and participate in awareness activities, and directs the Senate Clerk to transmit the resolution to Senator Stephen Meredith for delivery. The resolution does not create new regulatory requirements, funding, or enforcement mechanisms.
Impact
SR287 has no direct effect on Kentucky statutes, administrative regulations, or private legal obligations because it is a nonbinding Senate resolution. Its practical impact is symbolic and educational: it elevates public awareness of asthma and allergies, highlights health disparities and access-to-care concerns, and may encourage outreach, advocacy, and community events related to respiratory and allergy health.
Sentiment
The available record suggests broad support and a noncontroversial reception. The resolution was adopted by voice vote, and there are no committee transcripts or recorded floor debates indicating opposition. The tone of the bill is supportive and commemorative, emphasizing public health awareness and the seriousness of asthma and food allergies.
Contention
No notable contention is reflected in the available materials. Because the measure is a ceremonial awareness resolution rather than a policy bill, there is no evidence of disagreement over regulatory changes, spending, or mandates. The only substantive policy-adjacent point raised in the text is access to affordable insurance, medications, and medical devices, but it is presented as a general concern rather than a disputed provision.